International drugmakers are working with European authorities on emergency plans to keep medicines flowing into Greece if the country crashes out of the euro.
The Indian government announced an inquiry on Friday into the operations of the country's main drug regulator, just days after a parliamentary report exposed dysfunction within the agency and alleged serious irregularities in the drug approval process.
Friday, 27 Apr 2012 | Source: The Associated Press
Merck said Friday that its first-quarter profit jumped 67 percent despite lower-than-expected sales, due to lower spending on production, marketing and research as well as an arbitration charge a year ago.
The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with competitors.
Starting a small business is a risky proposition. If you’re worried about how yours might fare during a downturn, consider a recession-proof industry, which caters to ongoing demands. Its odds of weathering economic storms are better than those that don’t.
There’s growing federal momentum to undercut medical marijuana laws in states including Montana and California. Those laws are suffering more pushback under President Obama than President Bush. What now for medical marijuana patients?
More than two years after New Jersey approved a measure to legalize marijuana for chronically ill patients, the program may finally be on the verge of allowing dispensaries to open.
Not only was Oregon the first state to decriminalize pot in 1973, years before its glamorous neighbor to the south, but its medical marijuana program has operated with few glitches since it began in 1998. Now, it's an issue in a top statewide election race.
A majority of young doctors feel pessimistic about the future of the U.S. healthcare system, with the new healthcare law cited as the main reason, according to a survey released to Reuters on Wednesday.
Monday, 12 Mar 2012 | Posted By:
| Source: CNBC.com
Despite the perception about a lack of work, there are jobs that employers can’t fill. Applicants may lack training, or the jobs may not pay enough. Whatever the reason, jobs in many major sectors going unfilled.
Wednesday, 7 Mar 2012 | Source: The New York Times
India’s mass production of generic versions of drugs patented elsewhere helps poor people with treatment that would otherwise be too costly, but drug companies say the knockoffs stifle innovation. The New York Times reports.
Merck said Tuesday first-quarter earnings would fall below Wall Street's estimates, however, it still expects to reach its earnings forecast for the full year.
The makers of a deer antler velvet product are suing Major League Baseball for libel after the league told players to stop taking the performance enhancer so as not to risk testing positive for a steroid that wasn't listed as an ingredient.... Read More
In his message to Berkshire Hathaway shareholders earlier this week, Warren Buffett wrote, "My doctors and I have decided on a two-month treatment of daily radiation" for his just-diagnosed stage I prostate cancer.... Read More
Based on my discussions with several analysts, from reading their reports, I suspect that the earnings revisions occurred after the analysts had conversations with Mylan... Read More